Investor's Business Daily on MSN5d
Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock ...
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
(Bloomberg) -- US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.
Moderna’s mRNA-1273 is the third COVID-19 vaccine to be approved for use by the Medicines and Healthcare products Regulatory Agency (MHRA) and is the second mRNA vaccine after Pfizer/BioNTech ...
Investopedia on MSN12d
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in ChinaConcerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.
Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 years and older.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback